Updated on 5 November 2013
Affordability is driven by innovation, which in turn is driven by necessity. The ripple effect of Obamacare on medical devices and drug companies will invariably drive US companies to acquire, partner, strive for innovations that bring down costs resulting in industry consolidation in Asia. From having an Asia strategy to Asia-first strategy will now make more sense to them because of large underserved markets in this part of the world versus the 30 million people that Obamacare will add to the market.
BioSpectrum will be tracking these developments under our new section on Healthcare. Check it out at www.BioSpectrumAsia.com. You can also read, Biopreneur section on the site that showcases entrepreneurs driving innovation and affordability in Asia.